Edonia, a French startup specializing in transforming spirulina into a protein ingredient called Edo, has raised €15 million to move from laboratory demonstration to large-scale production. The funding will support industrialization of a microalgae-based ingredient that the company says can compete with meat on nutrition, cost, and taste. The announcement follows early commercial traction, a pilot production phase in Agen, and a growing pipeline of preorders from food industry clients.
Investor Support and Funding Structure
The round is led by French investment fund Swen Blue Ocean 2, with participation from European Union body EIT Food and venture capital firm Asterion Ventures, an existing backer. The financing also includes non-dilutive funding from Bpifrance through the France 2030 program and a bank financing component. This mix of equity and non-dilutive capital is designed to support industrial scale-up while preserving the company's balance sheet.
Technology and Product Positioning
Edonia focuses on spirulina, a microalgae known for its high protein content but still uncommon in daily diets. The company has developed Edo, an ingredient that can be incorporated into breads, prepared meals, and other food products. According to co-founder Hugo Valentin, the company has demonstrated that a microalgae-based ingredient can match meat on nutrition, price, and taste while being tested in real volumes with real customers.
Market Context and Alternative Protein Demand
The global alternative protein sector continues to attract investment as manufacturers seek sustainable ingredients with lower environmental footprints. Microalgae such as spirulina offer high protein density and can be cultivated with fewer land and water resources than animal agriculture. Edonia's approach addresses both the need for scalable production and consumer expectations around taste, cost, and nutritional quality.
Commercial Traction with Food Industry Partners
Founded in 2023, Edonia targets institutional catering and food manufacturing clients across Europe. The startup works with Newrest, a collective catering group, and Aliive, a brand under weight management specialist Dietbon. Edonia reports around twenty signed contracts with industry leaders, representing €30 million in preorders, and these agreements highlight rising demand from large food operators seeking alternative protein sources.
Early Industrialization in Agen
Edonia raised €2 million in 2024 to finance a first phase of industrialization. The earlier funding allowed the company to install a pilot production unit in Agen, structure its supply chain, and begin initial output. This stage helped the startup demonstrate that its technology could operate beyond the laboratory and prepare for larger-scale manufacturing.
New Production Site and International Ambitions
The new funding will support a full-scale production site within an existing facility operated by Maison Chancerelle, a Breton company known for canned seafood. Edonia expects the site to be operational within one year and to increase production volumes significantly. The company is targeting the European market as well as Japan and the United States to expand its B2B sales model.
Edonia's latest funding round signals growing investor confidence in alternative proteins made from microalgae. The company's shift from pilot production to a full-scale industrial site could determine whether its ingredient becomes a mainstream option for food manufacturers and caterers. With preorders in place and international ambitions, the French startup is positioned to test the scalability of its technology in a competitive protein market.